HALOZYME THERAPEUTICS INC

Ticker: HALO CUSIP: 40637H109 Class: EQTY

Bayesian Capital Management, LP's Holding History (CIK: 0001632551)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025
Shares 4,804 Value ($000) $323 Avg Close $67.27 Range $61.23 - $76.30
Q3 2025
Shares 34,482 Value ($000) $2,529 Avg Close $66.43 Range $51.78 - $79.50
Q2 2025
Shares 28,082 Value ($000) $1,461 Avg Close $56.90 Range $47.50 - $70.51
Q1 2025
Shares 16,400 Value ($000) $1,046 Avg Close $58.09 Range $47.52 - $66.00
Q2 2024
Shares 31,260 Value ($000) $1,637 Avg Close $43.86 Range $37.73 - $53.00
Q4 2023
Shares 31,500 Value ($000) $1,164 Avg Close $37.66 Range $32.83 - $42.82
Q2 2023
Shares 46,100 Value ($000) $1,663 Avg Close $34.12 Range $29.85 - $38.80
Q1 2023
Shares 37,500 Value ($000) $1,432 Avg Close $46.91 Range $32.83 - $57.00
Q4 2022
Shares 7,600 Value ($000) $432 Avg Close $51.20 Range $39.17 - $59.46
Q3 2022
Shares 16,100 Value ($000) $637 Avg Close $44.20 Range $38.03 - $52.98
Q2 2022
Shares 19,900 Value ($000) $876 Avg Close $43.25 Range $36.95 - $48.58
Q2 2021
Shares 7,800 Value ($000) $354 Avg Close $44.26 Range $38.65 - $51.57
Q1 2021
Shares 8,465 Value ($000) $353 Avg Close $45.65 Range $38.80 - $56.40
Q4 2017
Shares 22,800 Value ($000) $462 Avg Close $18.38 Range $16.58 - $21.13
Q2 2016
Shares 11,200 Value ($000) $97 Avg Close $9.87 Range $7.70 - $12.33